As of my last knowledge update in January 2022, mesothelioma incidence in the United States has been primarily linked to exposure to asbestos, a mineral once widely used in construction, insulation, and other industries. Mesothelioma is a rare and aggressive cancer that develops in the thin layer of tissue that covers most of the body’s internal organs, known as the mesothelium.
The incidence of mesothelioma in the U.S. has been declining in recent years due to stricter regulations on asbestos use, better workplace safety practices, and increased awareness of its dangers. However, it remains a significant health concern.
According to the American Cancer Society’s estimates from previous years, around 3,000 new cases of mesothelioma were diagnosed annually in the United States. However, these numbers may have changed slightly since then due to evolving factors such as changes in regulations, exposure risks, and advancements in diagnosis.
It’s important to note that the latency period for mesothelioma is long, often spanning several decades between exposure to asbestos and the development of symptoms. This means that even though asbestos use has decreased in recent years, individuals previously exposed may still develop mesothelioma or related diseases.
For the most current and accurate information on mesothelioma incidence in the United States, I recommend referring to updated statistics and reports from reputable sources such as the American Cancer Society, the Centers for Disease Control and Prevention (CDC), or other governmental health agencies.